Legend Biotech adds top scientific advisors to boost cell therapy pipeline and innovation.

Legend Biotech has engaged a team of leading scientific advisors with expertise in cell therapy, oncology, and immunology to guide its future research and pipeline development. This move aims to expand beyond its current portfolio, focusing on high unmet medical needs and advancing next-generation cell therapies. The advisors bring experience in clinical development, manufacturing, and translational research, reinforcing Legend Biotech's goal to become a comprehensive cell therapy company. This strategic input is expected to enhance patient access and unlock new therapeutic possibilities.